Cargando…
MitoTam-01 Trial: Mitochondrial Targeting as Plausible Approach to Cancer Therapy. Comment on Yap et al. Complex I Inhibitor of Oxidative Phosphorylation in Advanced Solid Tumors and Acute Myeloid Leukemia: Phase I Trials. Nat. Med. 2023, 29, 115–126
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526283/ https://www.ncbi.nlm.nih.gov/pubmed/37760446 http://dx.doi.org/10.3390/cancers15184476 |
| _version_ | 1785110985055404032 |
|---|---|
| author | Neuzil, Jiri Rohlena, Jakub Werner, Lukas Bielcikova, Zuzana |
| author_facet | Neuzil, Jiri Rohlena, Jakub Werner, Lukas Bielcikova, Zuzana |
| author_sort | Neuzil, Jiri |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10526283 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105262832023-09-28 MitoTam-01 Trial: Mitochondrial Targeting as Plausible Approach to Cancer Therapy. Comment on Yap et al. Complex I Inhibitor of Oxidative Phosphorylation in Advanced Solid Tumors and Acute Myeloid Leukemia: Phase I Trials. Nat. Med. 2023, 29, 115–126 Neuzil, Jiri Rohlena, Jakub Werner, Lukas Bielcikova, Zuzana Cancers (Basel) Comment MDPI 2023-09-08 /pmc/articles/PMC10526283/ /pubmed/37760446 http://dx.doi.org/10.3390/cancers15184476 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Comment Neuzil, Jiri Rohlena, Jakub Werner, Lukas Bielcikova, Zuzana MitoTam-01 Trial: Mitochondrial Targeting as Plausible Approach to Cancer Therapy. Comment on Yap et al. Complex I Inhibitor of Oxidative Phosphorylation in Advanced Solid Tumors and Acute Myeloid Leukemia: Phase I Trials. Nat. Med. 2023, 29, 115–126 |
| title | MitoTam-01 Trial: Mitochondrial Targeting as Plausible Approach to Cancer Therapy. Comment on Yap et al. Complex I Inhibitor of Oxidative Phosphorylation in Advanced Solid Tumors and Acute Myeloid Leukemia: Phase I Trials. Nat. Med. 2023, 29, 115–126 |
| title_full | MitoTam-01 Trial: Mitochondrial Targeting as Plausible Approach to Cancer Therapy. Comment on Yap et al. Complex I Inhibitor of Oxidative Phosphorylation in Advanced Solid Tumors and Acute Myeloid Leukemia: Phase I Trials. Nat. Med. 2023, 29, 115–126 |
| title_fullStr | MitoTam-01 Trial: Mitochondrial Targeting as Plausible Approach to Cancer Therapy. Comment on Yap et al. Complex I Inhibitor of Oxidative Phosphorylation in Advanced Solid Tumors and Acute Myeloid Leukemia: Phase I Trials. Nat. Med. 2023, 29, 115–126 |
| title_full_unstemmed | MitoTam-01 Trial: Mitochondrial Targeting as Plausible Approach to Cancer Therapy. Comment on Yap et al. Complex I Inhibitor of Oxidative Phosphorylation in Advanced Solid Tumors and Acute Myeloid Leukemia: Phase I Trials. Nat. Med. 2023, 29, 115–126 |
| title_short | MitoTam-01 Trial: Mitochondrial Targeting as Plausible Approach to Cancer Therapy. Comment on Yap et al. Complex I Inhibitor of Oxidative Phosphorylation in Advanced Solid Tumors and Acute Myeloid Leukemia: Phase I Trials. Nat. Med. 2023, 29, 115–126 |
| title_sort | mitotam-01 trial: mitochondrial targeting as plausible approach to cancer therapy. comment on yap et al. complex i inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase i trials. nat. med. 2023, 29, 115–126 |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526283/ https://www.ncbi.nlm.nih.gov/pubmed/37760446 http://dx.doi.org/10.3390/cancers15184476 |
| work_keys_str_mv | AT neuziljiri mitotam01trialmitochondrialtargetingasplausibleapproachtocancertherapycommentonyapetalcomplexiinhibitorofoxidativephosphorylationinadvancedsolidtumorsandacutemyeloidleukemiaphaseitrialsnatmed202329115126 AT rohlenajakub mitotam01trialmitochondrialtargetingasplausibleapproachtocancertherapycommentonyapetalcomplexiinhibitorofoxidativephosphorylationinadvancedsolidtumorsandacutemyeloidleukemiaphaseitrialsnatmed202329115126 AT wernerlukas mitotam01trialmitochondrialtargetingasplausibleapproachtocancertherapycommentonyapetalcomplexiinhibitorofoxidativephosphorylationinadvancedsolidtumorsandacutemyeloidleukemiaphaseitrialsnatmed202329115126 AT bielcikovazuzana mitotam01trialmitochondrialtargetingasplausibleapproachtocancertherapycommentonyapetalcomplexiinhibitorofoxidativephosphorylationinadvancedsolidtumorsandacutemyeloidleukemiaphaseitrialsnatmed202329115126 |